JLABS @ M2D2 QuickFire Challenge
Residency at JLABS @ M2D2
Winners
Third Pole is producing next generation cardio-pulmonary therapies that expand patient access. Our first product creates inhaled nitric oxide on-demand, on-site from air. Powered by this innovative portable technology licensed from Massachusetts General Hospital we eliminate the need for cumbersome compressed gas cylinders and enable the worldwide use of inhaled NO in settings outside of acute care.
The Challenge
We are looking for game-changing early-stage medical device innovations and therapeutic platforms across Johnson & Johnson’s strategic areas of interest:
- Cardiovascular
- Diabetes
- Neurovascular
- Orthopedics
- Surgery
- 力ion Care
Entrants must be committed to conducting their project at the M2D2 space in Lowell, MA.
Rewards and benefits
Why this challenge matters to us
At Johnson & Johnson Innovation, we believe the next great idea can come from anywhere – and that it’s just as likely to come from outside of our walls as from inside our research labs. That’s why Johnson & Johnson Innovation is excited to announce JLABS @ M2D2, our accelerator initiative in partnership with the northeast region’s premier medtech incubator, University of Massachusetts Medical Device Development Center (M2D2) in Lowell, Massachusetts. JLABS @ M2D2 is our seventh JLABS facility and the first specifically focused on the early-stage medical device ecosystem.
Timeline
Check out the blog poston the J&J website!